In contrast to its role in IBD and CRC, heightened GSDMB levels are intricately linked to the aggressive characteristics of breast cancer, specifically its invasive nature, progression, and metastatic potential (59, 100, 101). Here, GSDMB is linked to inflammatory bowel disease.